SAG-AFTRA’s Nationwide Board overwhelmingly accredited 2025’s Commercials Contracts tentative agreements reached with the Joint Coverage Committee April 12, that means…
Read More
FDA approves Dupixent for persistent spontaneous urticaria
The U.S. Meals and Drug Administration has authorized Dupixent (dupilumab) for the therapy of adults and adolescents with persistent spontaneous…
Read More
